NYSE: TMO
Thermo Fisher Scientific Inc Stock

TMO Price
$471.88
Fair Value Price
N/A
Market Cap
$186.37B
52 Week Low
$255.30
52 Week High
$489.30
P/E
50.69x
P/B
6.24x
P/S
5.28x
PEG
1.21x
Dividend Yield
0.17%%
Revenue
$26.25B
Earnings
$3.71B
Gross Profit Margin
45.4%%
Operating Margin
18.59%%
Net Profit Margin
14.1%%
Debt to Equity
1.06
Operating Cash Flow
$5B
Beta
0.88
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
45
Industry average

Reasons for this score

TMO ($471.88) is trading below its intrinsic value of $1,357.69, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
TMO is poor value based on its earnings relative to its share price (50.69x), compared to the US market average (46.84x)
Valuation
TMO is poor value based on its earnings relative to its share price (50.69x), compared to the US Diagnostics & Research industry average (43.65x)
Valuation

1 of 13

TMO News

Valuation

TMO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
50.69x
Industry
43.65x
Market
46.84x
TMO is poor value based on its earnings relative to its share price (50.69x), compared to the US market average (46.84x)
Valuation
TMO is poor value based on its earnings relative to its share price (50.69x), compared to the US Diagnostics & Research industry average (43.65x)
Valuation

TMO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.24x
Industry
6.2x
Market
63.22x
TMO is good value based on its book value relative to its share price (6.24x), compared to the US market average (63.22x)
Valuation
TMO is poor value based on its book value relative to its share price (6.24x), compared to the US Diagnostics & Research industry average (6.2x)
Valuation

TMO price to earnings growth (PEG)

For valuing profitable companies with growth potential
TMO is poor value relative to its rate of earnings growth, measured by PEG ratio (1.21x)
Valuation

TMO's financial health

Profit margin

Revenue
$6.2B
Net Income
$788.0M
Profit Margin
12.6%%
TMO's Earnings (EBIT) of $4.88B can safely cover interest payments on company debt ($21.31B)
Financials
TMO's profit margin has decreased (-0.1%%) in the last year from (14.2%%) to (14.1%%)
Financials

Assets to liabilities

Assets
$58.7B
Liabilities
$30.1B
Debt to equity
0.7
TMO's short-term assets ($15.78B) exceed its short-term liabilities ($6.01B)
Financials
TMO's long-term liabilities ($25.71B) exceed its short-term assets ($15.78B)
Financials
TMO's debt has increased relative to shareholder equity (1.06), over the past 5 years ago (1.02)
Financials
TMO's debt to equity ratio (1.06) is considered high
Financials

Cash flow

Operating
$356.0M
Investing
-$260.0M
Financing
$619.0M
TMO's operating cash flow ($5.27B) is sufficient to service the company's debt ($21.31B)
Financials

Thermo Fisher Scientific Stock FAQ

(NYSE: TMO) Thermo Fisher Scientific trades on the NYSE under the ticker symbol TMO. Thermo Fisher Scientific stock quotes can also be displayed as NYSE: TMO.
(NYSE: TMO) Thermo Fisher Scientific stock price per share is $471.88 today (as of Oct 29, 2020).
(NYSE: TMO) Thermo Fisher Scientific's 52-week high was $489.30, and its 52-week low was $255.30. It is currently -3.56%% from its 52-week high and 84.83%% from its 52-week low.
(NYSE: TMO) Thermo Fisher Scientific's market cap is $186.37B, as of Oct 30, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Thermo Fisher Scientific's market cap is calculated by multiplying TMO's current stock price of $471.88 by TMO's total outstanding shares of 394,951,104.
(NYSE: TMO) Thermo Fisher Scientific currently has 394,951,104 outstanding shares. With Thermo Fisher Scientific stock trading at $471.88 per share, the total value of Thermo Fisher Scientific stock (market capitalization) is $186.37B.

Thermo Fisher Scientific stock was originally listed at a price of $44.00 in Dec 31, 1997. If you had invested in Thermo Fisher Scientific stock at $44.00, your return over the last 22 years would have been 972.45%%, for an annualized return of 11.39%%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics